Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Europa Metals, Kodal Minerals, Oriole Resources, Buccaneer Energy, Bluefield Solar, Santhera Pharmaceuticals - Small Cap Week in Review

Europa Metals, Kodal Minerals, Oriole Resources, Buccaneer Energy, Bluefield Solar, Santhera Pharmaceuticals - Small Cap Week in Review

Europa Metals Ltd (AIM:EUZ, JSE:EUZ) is planning a reverse takeover of Marula Africa, giving it access to producing and near-producing copper, lithium, and manganese assets across Africa. Executive chairman Myles Campion says it’s a transformative deal that will deliver strong cash flow and reshape the company. Watch more

Kodal Minerals PLC (AIM:KOD) has officially opened its Bougouni Lithium Project in Mali, with the country’s president attending. CEO Bernard Aylward says first shipments are on track for early December, marking the start of revenues. Watch more

Oriole Resources PLC (AIM:ORR) has struck a deal with BCM International, including $900,000 in cash and a further $300,000 in direct drilling expenditure for a 2,950-metre maiden drilling program at the MB01-N target in Cameroon. CEO Martin Rosser says it validates their exploration strategy and avoids shareholder dilution. Watch more

Buccaneer Energy Plc (AIM:BUCE) has spudded its Allar #1 well in East Texas and plans to monetise gas through Bitcoin mining. CEO Paul Welch says it could add $75,000 a month in cash flow by turning waste gas into power. Watch more

Bluefield Solar Income Fund (LSE:BSIF) has launched a strategic review and formal sale process to tackle its share price discount. Bluefield Partners' managing partner James Armstrong says the aim is to unlock shareholder value and boost liquidity. Watch more

Santhera Pharmaceuticals (SIX:SANN) has shared long-term data showing its Duchenne muscular dystrophy drug AGAMREE avoids many steroid side effects. Chief medical officer Dr Shabir Hasham says the results support wider global rollout and better quality of life for patients. Watch more

Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK